Repeated bullying causes a depression-like syndrome in mice that is associated with lasting changes in gene expression in the hippocampus
Repeated defeat by dominant animals causes
a depression-like syndrome in mice that is accompanied at the molecular
level by changes in gene expression in the hippocampus, according
to an article published online February 26th by Nature Neuroscience.
Researchers found that silencer molecules
had halted gene expression for a key protein in the hippocampus
in mice that had developed the social-withdrawal behaviors. By activating
a compensatory mechanism, an antidepressant temporarily restored
animals’ sociability and protein expression, the silencer molecules
blocked gene expression after the antidepressant was discontinued.
A true cure for depression would likely have
to target this persistent stress-induced scar, said the researchers,
led by Eric Nestler, MD, of The University of Texas Southwestern
Medical Center.
In the study, mice exposed to aggression
by a different dominant mouse daily for 10 days became socially
defeated; they vigorously avoided other mice, even weeks later.
Expression of a representative gene in the hippocampus decreased
three-fold and remained suppressed for weeks. However, chronic treatment
with imipramine restored expression of the gene for brain derived
neurotrophic factor (BDNF) to normal levels and reversed the social
withdrawal behavior. BDNF in the hippocampus has been linked to
memory, learning and depression, but Nestler said social defeat
stress probably similarly affects other genes there as well.
The researchers pinpointed how social defeat
changes the BDNF gene’s internal machinery. They traced the gene
expression changes to long-lasting modifications in histones, proteins
that regulate the turning on-and-off of genes via a process called
methylation. Methyl groups, the silencer molecules, attach themselves
to the histones, turning off the gene. Notably, imipramine was unable
to remove these silencer molecules, suggesting that they remained
a latent source of vulnerability to future depression-like responses
to stress.
Imipramine reversed the suppressed BDNF gene
expression by triggering a compensatory mechanism, acetylation,
in which molecular activators attach themselves to the gene and
overcome the silencer molecules. Imipramine turned off an enzyme
(Hdac5) that degrades the activators, allowing them to accumulate.
“The molecular scar induced by chronic stress in the hippocampus,
and perhaps elsewhere in the brain, can’t be easily reversed,” said
Nestler. “To really cure depression, we probably need to find new
treatments that can remove the silencer molecules.”
|